Human Leukocyte Antigen Class II Alleles Influence Levels of Antibodies to the Plasmodium falciparum Asexual-Stage Apical Membrane Antigen 1 but Not to Merozoite Surface Antigen 2 and Merozoite Surface Protein 1

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2762-2771

  Johnson, Armead H ^a   Leke, Rose G F ^c   Mendell, Nancy R ^d   Shon, Dewon ^d   Suh, Young Ju ^e,f   Bomba Nkolo, Dennis ^c   Tchinda, Viviane ^c   Kouontchou, Samuel ^c   Thuita, Lucy W ^b   Van Der Wel, Anne Marie ^g   Thomas, Alan ^g   Stowers, Anthony ^h   Saul, Allan ^h,i   Zhou, Ainong ^b   Taylor, Diane W ^b   Quakyi, Isabella A ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d Stony Brook University   (United States)

^e Seoul National University   (South Korea)

^f Seoul National University Hospital   (South Korea)

^g BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APICAL MEMBRANE ANTIGEN 1; HLA ANTIGEN CLASS 2; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; RECOMBINANT PROTEIN; RHOPTRY ASSOCIATED PROTEIN 1; RHOPTRY ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICA; AGE; AGED; ALLELE; AMINO TERMINAL SEQUENCE; ANALYSIS OF VARIANCE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASEXUAL REPRODUCTION; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CAMEROON; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; GENE FREQUENCY; GENES, MHC CLASS II; HAPLOTYPES; HEMOGLOBIN, SICKLE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 11144353891     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2762-2771.2004     Document Type: Article

References (52)

1. Al-Yaman, F., B. Genlon, R. F. Anders, M. Falk, T. Triglia, D. Lewis, J. Hii, H.-P. Beck, and M. P. Alpers. 1994. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am. J. Trop. Med. Hyg. 51:593-602.
2. Al-Yaman, F., B. Genlon, K. J. Krammer, S. P. Chang, G. S. Hui, M. Baisor, and M. P. Alpers. 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am. J. Trop. Med. Hyg. 54:443-448.
3. Beck, H.-P., I. Felger, M. Barker, T. Bugawan, B. Genton, N. Alexander, E. Jazwinska, H. Erlich, and M. Alpers. 1995. Evidence of HLA class II association with antibody response against the malaria vaccine SPf66 in a naturally exposed population. Am. J. Trop. Med. Hyg. 53:284-288.
4. Blackman, J. J., H.-G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite surface during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
5. Branch, O. H., V. Udhayakumar, A. W. Hightower, A. J. Oloo, W. A. Hawley, B. L. Nahlen, P. B. Bloland, D. C. Kaslow, and A. A. Lai. 1998. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am. J. Trop. Med. Hyg. 58:211-219.
6. Brown, A. E., D. Chandanayingyong, S. V. Fuggle, and H. K. Webster. 1989. Immune responses to the circumsporozoite protein of Plasmodium falciparum in relation to HLA-DR type. Tissue Antigens 34:200-204.
7. Bruce-Chwatt, L. J. Essential malariology, p. 35-52. William Heinemann Medical Books, Ltd., London, United Kingdom.
8. Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. N. Hui. 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
9. Egan, A. F., J. Morris, G. Barnish, S. Allen, B. M. Greenwood, D. C. Kaslow, A. A. Holder, and E. M. Riley. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
10. Egan, A. F., P. Burghaus, P. Druilhe, A. A. Holder, and E. M. Riley. 1999. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 21:133-139.
11. Epping, R. J., S. D. Goldstone, L. T. Ingram, J. A. Upcroft, R. Ramasamy, J. A. Cooper, G. R. Bushell, and H. M. Geysen. 1988. An epitope recognized by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol. Biochem. Parasitol. 28:1-10.
12. George, E. I., and R. E. McCullough. 1993. Variable selection via Gibbs sampling. J. Am. Stat. Assoc. 88:881-889.
13. Germain, R. N. 1999. Antigen processing and presentation, p. 287-340. In W. E. Paul (ed.), Fundamental immunology. Lippincott-Raven, Philadelphia, Pa.
14. Graves, P. M., K. Bhatia, T. R. Burkot, M. Prasad, R. A. Wirtz, and P. Beckers. 1989. Association between HLA type and antibody response to malaria sporozoite and gametocyle epitopes is not evident in immune Papua New Guineans. Clin. Exp. Immunol. 78:418-423.
15. Herrera, M. A., F. Rosero, S. Herrera, P. Caspers, D. Rotmann, F. Sinigaglia, and U. Certa. 1992. Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect. Immun. 60:154-158.
16. Hodder, A. N., P. E. Crewther, and R. F. Anders. 2001. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69:3286-3294.
17. Holder, A. A., J. S. Sandhu, V. Hillman, L. S. Davey, S. C. Nicholls, H. Cooper, and M. J. Lockyer. 1987. Processing of the precursor to the major merozoite antigens of Plasmodium falciparum. Parasitology 94:199-208.
18. Holder, A. A. 1994. Proteins on the surface of the malaria parasite and cell invasion. Parasitology 108:S5-S18.
19. Howell, S. A., C. Withers-Martinez, C. H. Kicken, A. W. Thomas, and M. J. Blackman. 2001. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem. 276:31311-31320.
20. Hui, G. S. N., A. Hashimoto, and S. P. Chang. 1992. Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum. Infect. Immun. 60:1422-1433.
21. Jakobsen, P. H., M. M. Lemnge, Y. A. Abu-Zeid, W. A. Msangeni, F. M. Salum, J. I. K. Mhina, J. A. Akida, A. S. Ruta, A. M. Ronn, P. M. H. Heegaard, R. G. Ridley, and I. C. Bygbjerg. 1996. Immunoglobulin G reactivities to rhoptry-associated protein-1 associated with decreased levels of Plasmodium falciparum parasitemia in Tanzanian children. Am. J. Trop. Med. Hyg. 55:642-646.
22. Jepson, A., W. Banya, F. Sisay-Joof, M. Hassan-King, C. Nunes, S. Bennett, and H. Whittle. 1997. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect. Immun. 65:872-876.
23. Johnson, A. H., R. Leke, L. Harun, C. Ginsberg, J. Ngogang, A. Stowers, A. Saul, and I. A. Quakyi. 2000. Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect. Immun. 68:2231-2236,
24. 19) variants secreted from Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 63:283-289.
25. Kocken, C. H., A. M. van der Wel, M. A. Dubbeld, D. L. Narum, F. M. van de Rijke, G. J. van Gemert, X. van der Linde, L. H. Bannister, C. Janse, A. P. Waters, and A. W. Thomas. 1998. Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J. Biol. Chem. 273:15119-15124.
26. McDevitt, H., and M. Sella. 1967. Genetic control of the antibody response. II. Further analysis of the specificity of determinant specific control and genetic analysis of the response to (H, G)-A-L in CBD and C57 mice. J. Exp. Med. 126:969-978.
27. Migot-Nabias, F., A. J. F. Luty, P. Ringwald, M. Vaillant, B. Dubois, A. Renault, R. J. Mayombo, T. N. Minh, N. Fievet, J. R. Mbessi, P. Millet, and P. Deloron. 1999. Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am. J. Trop. Med. Hyg. 61:488-494.
28. Nardin, E. H., G. A. Oliveira, J. M. Calvo-Calle, Z. R. Castro, R. S. Nussenzweig, B. Schmeckpeper, B. F. Hall, C. Diggs, S. Bodison, and R. Edelman. 2000. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J. Infect. Dis. 182:1486-1496.
29. Narum, D. L., G. W. Welling, and A. W. Thomas. 1993. Ion-exchange-immunoaffinity purification of a recombinant baculovirus Plasmodium falciparum apical membrane antigen, PF83/AMA-1. J. Chromatogr. 657:357-363.
30. Narum, D. L., and A. W. Thomas. 1994. Differential localization of full-length and processed forms of PF83/AMA-1, an apical membrane antigen of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 67:59-68.
31. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 193:1403-1412.
32. Perrin, L. H., E. Ramirez, P. H. Lambert, and P. A. Miescher. 1981. Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature 289:301-303.
33. Pimtanothai, N., C. K. Hurley, R. Leke, W. Klitz, and A. H. Johnson. 2001. HLA-DR and -DQ polymorphism in Cameroon. Tissue Antigens 58:1-8.
34. Quakyi, I. A. 1980. The development and validation of an enzyme-linked immunosorbent assay for malaria. Trop. Med. Parasitol. 42:325-333.
35. Quakyi, I. A., D. W. Taylor, A. H. Johnson, J. B. Allotey, J. A. Berzofsky, L. H. Miller, and M. F. Good. 1992. Development of a malaria T-cell vaccine for blood stage immunity. Scand. J. Immunol. Suppl. 11:9-16.
36. Quakyi, I. A., R. G. Leke, R. Befidi-Mengue, M. Tsafack, D. Bomba-Nkolo, L. Manga, V. Tchinda, E. Njeungue, S. Kouontchou, J. Fogako, P. Nyonglema, L. Harun, R. Djokam, G. Sama, A. Eno, R. Megnekou, S. Metenou, L. Ndountse, A. Same-Ekobo, G. Alake, J. Meli, L. Ngu, F. Tietche, J. Lohoue, J. Mvondo, E. Wansi, R. Leke, A. Folefack, J. Bigoga, C. Bomba-Nkolo, V. Titanji, A. Walker-Abbey, M. A. Hickey, A. H. Johnson, and D. W. Taylor. 2000. The epidemiology of Plasmodium falciparum malaria in two Cameroonian villages: Simbok and Etoa. Am. J. Trop. Med. Hyg. 63:222-230.
37. Ramasamy, R. 1987. Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a myristilated 45 kDa merozoite membrane glycoprotein. Immunol. Cell Biol. 65:419-424.
38. Riley, E. M., S. J. Allen, J. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schonfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321-337.
39. Riley, E. M., O. Olerup, S. Benneth P. Rowe, S. J. Allen, M. J. Blackman, M. Troye-Blomberg, A. A. Holder, and B. M. Greenwood. 1992. MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Int. Immunol. 4:1055-1063.
40. Saul, A., G. Lawrence, A. Smillie, C. M. Rzepczyk, C. Reed, D. Taylor, K. Anderson, A. Stowers, R. Kemp, A. Allworth, R. F. Anders, G. V. Brown, D. Pye, P. Schoofs, D. O. Irving, S. L. Dyer, G. C. Woodrow, W. R. S. Briggs, R. Reber, and D. Sturchler. 1999. Human phase 1 vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine 17:3145-3159.
41. Shaffer, A. L., J. A. Falk-Wade, V. Tortorelli, A. Cigan, C. Carter, K. Hassan, and C. K. Hurley. 1992. HLA-DRw52-associated DRB1 alleles: identification using polymerase chain reaction amplified DNA, sequence specific oligonucleotide probes, and a chemiluminescent detection system. Tissue Antigens 39:84-91.
42. Smythe, J. A., R. L. Coppell, G. V. Brown, R. Ramasamy, D. J. Kemp, and R. F. Anders. 1988. Identification of two integral membrane proteins of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85:5195-5199.
43. Snow, R. W., M. Craig, U. Deichmann, and K. Marsh. 1999. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. W. H. O. 77:624-640.
44. Stephens, H. A. F., A. E. Brown, D. Chandanayingyong, H. K. Wehster, M. Sirikong, P. Longta, R. Vangseratthana, D. M. Gordon, S. Lekmak, and E. Rungruang. 1995. The presence of the HLA class II allele DPR1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen. Eur. J. Immunol. 25:3142-3147.
45. Stowers, A., D. Taylor, N. Prescott, Q. Cheng, J. Cooper, and A. Saul. 1997. Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect. Immun. 65:2329-2338.
46. Stowers, A., K. J. Spring, and A. Saul. 1995. Preparative scale purification of recombinant proteins to clinical grade by isotachophoresis. Bio/Technology 13:1498-1503.
47. Sturchler, D., R. Berger, C. Rudin, M. Just, A. Saul, C. Rzepczyk, G. Brown, R. Anders, R. Coppel, G. Woodrow, D. Pye, F. Sorenson, D. Gillessen, H. Matile, and R. Reber-Liske. 1995. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults. Am. J. Trop. Med. Hyg. 53:423-431.
48. Suh, Y. J., S. J. Finch, and N. R. Mendell. 2001. Application of a Bayesian method for optimal subset regression to linkage analysis of Q1 and Q2. Genetic Epidemiol. 21(Suppl. 1):S706-S711.
49. Taylor, R. R., S. J. Allen, B. M. Greenwood, and E. M. Riley. 1998. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58:406-413.
50. Thomas, A. W., J. A. Jeans, G. H. Mitchell, T. Alderson, and S. Cohen. 1984. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol. Biochem. Parasitol. 13:187-199.
51. Thomas, A. W., J.-F. Trape, C. Rogier, A. Goncalves, V. E. Rosario, and D. L. Narum. 1994. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am. J. Trop. Med. Hyg. 51:730-740.
52. Tolle, R., K. Fruh, O. Doumbo, O. Koita, M. M'Diaye, A. Fischer, K. Dietz, and H. Bujard. 1993. A prospective study of the association between the human humoral immune response to plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect. Immun. 61:40-47.